Rahsaan Thompson is CLO at ZEVRA THERAPEUTICS, INC. (ZVRA). They have made 1 open-market trade across 1 company since 2025, most recently 2026-08-14.
CIK 0001788524
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZVRA | 37,569 | $373K |
| GRTS | 58,698 | $2K |
| Total | $375K |
Shares reported on the most recent Form 4, priced at the 2026-08-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZVRA | SELL · 10b5-1 | 2026-08-14 | 2026-08-17 | $11.13 | $475K | +3.0% | +2.6% | — |
| ZVRA | SELL · 10b5-1 | 2026-06-22 | 2026-06-23 | $12.68 | $438K | +6.3% | -5.1% | -11.3% |
| ZVRA | SELL · 10b5-1 | 2026-05-11 | 2026-05-13 | $11.30 | $20K | -8.7% | +11.8% | +0.3% |
| ZVRA | SELL | 2026-01-30 | 2026-02-02 | $8.83 | $36K | -9.3% | -3.6% | +8.5% |
| ZVRA | SELL · 10b5-1 | 2025-06-26 | 2025-06-30 | $9.21 | $442K | +43.9% | +26.2% | +9.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.